Status:
COMPLETED
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases
Lead Sponsor:
Changhai Hospital
Collaborating Sponsors:
RenJi Hospital
Nanfang Hospital, Southern Medical University
Conditions:
Gastric Diseases,
Gastric Ulcer,
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
A new Magnetic-controlled Capsule Endoscopy (MCE) was developed by ANKON and got SFDA's approval in China in 2013. It has recently been evaluated to compare the diagnostic accuracy of MCE with that of...
Eligibility Criteria
Inclusion
- Patients presented with gastric symptoms and ready for the first Upper GI endoscopy
- Patients with known focal gastric diseases: gastric ulcer, gastric polyps, early gastric cancer, gastric stromal tumors and so on.
- Age of 18 years to 70 years
Exclusion
- Patients with impaired bowel movement from ileus or organic digestive diseases
- Patients with known large and obstructing tumors of the upper GI tract
- Patients after upper GI surgery or abdominal surgery altering GI anatomy
- Patients under full anticoagulation
- Patient in poor general condition
- Patients using equipment that may be affected by radio transmission
- Patients using equipment that may be affected by magnetic field
- Pregnancy or suspected pregnancy
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT02219529
Start Date
August 1 2014
End Date
February 1 2015
Last Update
July 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Changhai Hospital
Shanghai, China, 200433